Road to Recovery or Déjà Vu?

This year isn’t over yet but questions abound about the pandemic, the economy, politics and the financial markets. As we end 2020 and peek into 2021, please join Chief Investment Officer Larry Adam with special guests Washington Policy Analyst Ed Mills and Raymond James Biotechnology Analyst Steve Seedhouse on Dec. 7 at 4:15 p.m. ET as they discuss the financial market impact from surging COVID-19 cases and hospitalizations, optimism surrounding vaccines and therapeutics, and the unfolding D.C. political dynamics.